Global Oligonucleotide Synthesis Market to Grow at 12.71% During 2022-2027, Impelled by the Increasing COVID-19 Cases

May 10, 2021

According to the latest report by IMARC Group, titled “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global oligonucleotide synthesis market reached a value of US$ 2.4 Billion in 2021. Oligonucleotide synthesis is the chemical amalgam of short fragments of the nucleic acids produced through enzymatic chemistry and genetic engineering. The technique is beneficial in current laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis provides rapid and inexpensive access to custom-made oligonucleotides for various end users through Deoxyribonucleic acid (DNA) synthesizers for self-consumption. It is used to develop primers and probes in recombinant DNA technologies to develop monoclonal antibodies. Oligonucleotide synthesis is also utilized in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Oligonucleotide Synthesis Market Trends:

The rapid outbreak of coronavirus disease (COVID-19) and an imminent need for a potential treatment represent one of the key factors driving the market growth. This is further facilitated by the ongoing development efforts of mRNA and DNA vaccines as a cure to the disease. The market is also driven by the increasing requirement to develop novel diagnostic techniques and effective therapies to treat chronic ailments. The rising geriatric population and the demand for personalized medicines are acting as another major growth-inducing factor. In addition to this, advances in purification and quality control technologies are enabling a significant reduction in the overall cost of oligonucleotide techniques while substantially increasing the quality and yield. This, in turn, is promoting the application of oligonucleotide synthesis in a range of available modifications, which is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and the introduction of various oligonucleotide-based therapies to treat viral infections, rare genetic disorders, and neuromuscular conditions, are contributing to the market growth. Looking forward, the market is expected to grow at a CAGR of 12.71% during 2022-2027.

Market Summary:

  • On the basis of the product, the market has been divided into synthesized oligonucleotide products, reagents, equipment and services.
  • Based on end use, the market has been classified into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories and academic research institutes.
  • Based on the application, the market has been classified into PCR primers, PCR assays and panels, sequencing, DNA microarrays, Fluorescence in-situ hybridization (FISH), antisense oligonucleotides and others.
  • On a regional basis, the market has been spread across North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Oligonucleotide Synthesis Market to Grow at 12.71% During 2022-2027, Impelled by the Increasing COVID-19 Cases
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More